News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Rachna Shroff: The women in GI Oncology who are moving the needle
Rachna Shroff
Jan 29, 2025, 12:35

Rachna Shroff: The women in GI Oncology who are moving the needle

Rachna Shroff, Associate Director of Clinical Research at the University of Arizona Cancer Center, shared a post on LinkedIn:

“There are some passion projects that are worth the effort!

Thank you Vaniam Group for this wonderful event and to our sponsors!

Most importantly, thank you to the women in GI Oncology who are moving the needle.”

 Rachna Shroff: The women in GI Oncology who are moving the needle

cancer fight against cancer GI oncology Global fight against cancer OncoDaily Oncology Rachna Shroff University of Arizona Cancer Center Vaniam Group
Special Coverage
Blog
Aug 2, 2025, 19:41
Michael Sapienza: Hopeful that Secretary Kennedy Will Reinforce the Tremendous Progress in Prevention Through No-Cost CRC Screenings
Blog
Aug 2, 2025, 19:31
Annabelle Gurwitch: My 5 Year Cancerversary
Blog
Aug 2, 2025, 19:14
Patrick C. Ma: Congratulations to Hyma Polimera for Her Robert A. Winn Excellence in Clinical Trials Award Program CDA
Opinion
Aug 2, 2025, 18:28
Mark Lawler: Cancer Is a No-Brainer - Isolationism in Health Research Is Brainless
Blog
Aug 2, 2025, 18:22
Ashish M. Kamat: Such an Energizing and Impactful BCANTT25
Insight
Aug 2, 2025, 18:14
Jonathan Friedberg: "A Cure, My Kingdom for a Cure" - CAR-T in Refractory Myeloma
Blog
Aug 2, 2025, 18:08
Deepa Rangachari: Training for Community-based Careers
Insight
Aug 2, 2025, 18:02
Anirban Maitra: "Anti-Medicine" Food
Insight
Aug 2, 2025, 17:54
Fred Hirsch: Still A Long Way To Go in Small Cell Lung Cancer
Blog
Aug 2, 2025, 17:50
2025 IPOS/COSA World Congress Announced Accepted Abstracts
Immune Oncology
Aug 2, 2025, 17:17
Real-World Study Confirms Nivolumab Plus Cabozantinib Improves Survival in Metastatic RCC
Science
Aug 2, 2025, 16:59
Myeloma Paper of the Day, August 2nd, Suggested by Robert Orlowski